INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)
$3.58 -0.41 (-10.2757%)
Analysed INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) News Sources
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
14-04-2026
yahoo.com
Why The Insight Molecular Diagnostics (IMDX) Story Is Shifting After Cash Raise And FDA Catalyst
13-04-2026
yahoo.com
How The Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Funding And FDA Catalyst
30-03-2026
yahoo.com
Insight Molecular Diagnostics Inc. Q4 2025 Earnings Call Summary
27-03-2026
moby.co
Insight Molecular Diagnostics: Q4 Earnings Snapshot
26-03-2026
yahoo.com
IMDX Submits GraftAssureDx for FDA Review and Reports Q4 2025 Results
26-03-2026
yahoo.com
iMDx to Release Fourth Quarter 2025 Results on March 26, 2026 and Attend Needham Virtual Healthcare Conference
20-03-2026
yahoo.com
How Insight Molecular Diagnostics (IMDX) Story Is Shifting With New Capital And GraftAssureDx Milestones
14-03-2026
yahoo.com
Second Study Affirms Superiority of iMDx GraftAssure Assay’s Proprietary dd-cfDNA Combination Model Score
13-03-2026
yahoo.com
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
03-03-2026
yahoo.com
What is the current price of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)?
The current price of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) is $3.58.
INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) since the previous trading day is $-0.41.
INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) since the previous trading day is -10.2757%.
What is the most recent average sentiment score for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)?
The most recent average sentiment score for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)?
The most recent sentiment for INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ) is .
SEC-8K** Filing Available For INSIGHT MOLECULAR DIAGNOSTIC (IMDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.